Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Cue Biopharma Inc. (CUE)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Nantahala Capital Management

Wilmot B. Harkey And Daniel Mack

2,325,388 $56,995 -8% 1.79%
2.
VenBio Select Advisor

Kurt Von Emster

1,870,000 $45,834 0.9%
3.
Slate Path Capital

David Greenspan

870,694 $21,341 1.25%
4.
Corriente Advisors

Mark Hart Iii

659,987 $16,176 -20% 10.48%
5.
Woodline PartnersKarl

Michael Rockefeller And Kroeker

659,395 $16,162 0.64%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$15.30 5,000 Director 677,500 2020-09-30 Filing
$15.00 5,000 Director 672,500 2020-09-29 Filing
$25.24 2,953 Director 158,452 2020-06-24 Filing
$24.64 4,547 Director 155,499 2020-06-24 Filing
$7.90 15,025 Officer 17,125 2019-06-10 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$20.00 13,374 Officer 17,125 2020-08-05 Filing
$20.00 13,274 Officer 17,125 2020-08-05 Filing
$20.01 800 Officer 34,558 2020-08-05 Filing
$20.05 201 Officer 17,125 2020-08-04 Filing
$20.00 6,425 Officer 17,125 2020-08-03 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 10,033 $245,909 0%
2. 2,442 $59,853 0%
3. 1,931,756 $47,349 0%
4. 1,337,660 $32,785 0%
5. 1,026,881 $25,169 0%
News See All